*Refresh the page if the below document does not appear.
Pharma stocks gain momentum in an otherwise weak market
The pharma index has hiked to 3.5% during this week whereas a decline of 1.5% has been observed in the benchmark index. Top 3 Nifty gainers includes Abbott India (almost 5% gain), Pfizer (nearly 4.5% gain), Zydus Life (about 3% gain).
IQVIA collaborates with Dr. Reddy's lab to develop CRM solution
Dr. Reddy’s laboratories has come in an agreement with IQVIA to bring its Orchestrated Customer Engagement (OCE) platform to the entire field force and marketing teams in India. It will be able to link all fields of management together and make customer engagement more convenient.
US FDA issues 3 observations to Torrent Pharma's Gujarat unit
Torrent Pharma stated that a form 483 with 3 observations have been issued by US FDA after an inspection of its manufacturing unit in Indrad, Gujarat. The company’s statement mentioned that none of the observations are related to data integrity and they will address them as soon as possible.
US regulatory authority issues warning letter to Lupin's Tarapur branch
The company said that it believes that the issuance of letter won’t have much of an impact and certainly won’t cause disruption of supplies or revenue generation from operations in this branch.
MoHFW Commitee sends proposal to strengthen state FDAs of some states
The Parliamentary Standing Committee for the Ministry of Health and Family Welfare has prompted the centre to submit a response on the submitted project proposals from the five states of Maharashtra, Uttar Pradesh, Bihar, Tamil Nadu and Karnataka on the topic of strengthening the FDA of these states.
Lupin launches Sildenafil oral suspension in US market
On Thursday, Lupin announed the launch of Sildenafil for oral suspension, 10 mg/mL which is a generic equivalent of Revatio for oral suspension, 10 mg/mL of Viatris Specialty LLC, in the US market. This product has estimated annual sales of USD 64 Million in the US territory.
Eugia US LLC recalls Acyclovir Sodium injection from the market
The company has voluntarily recalled the lot
number AC22006 of AuroMedics Acyclovir
Sodium Injection 500 mg per 10 mL (50
mg/mL), 10 mL single-dose vials after the
complaint was filed for the presence of dark
red, brown and black particulate inside the
vial.
